BHLHE41 and renal cell adenocarcinoma: In addition to RCC, BHLHE41/DEC2 promotes the development of a type of acute myelogenous leukemia (AML) with mixed lineage leukemia (MLL) gene rearrangement by the t(6;11) (q27;p23) translocation, named MLL-AF6.